Literature DB >> 26629003

The flavonoid luteolin enhances doxorubicin-induced autophagy in human osteosarcoma U2OS cells.

Baoliang Zhang1, Xin Yu2, Hong Xia3.   

Abstract

Luteolin (LUT), a flavone, which is universally present as constituent of medicinal plants as well as some vegetables and spices, has been demonstrated display specific anti-carcinogenic effects. However, the mechanisms by which LUT inhibits human osteosarcoma growth remain unknown. The effects of LUT on cell growth in human osteosarcoma U2OS cells were measured by MTT assay and flowcytometry. The effects of LUT on morphological markers of autophagy in U2OS were analyzed by fluorescence microscopy and electron microscopy. Autophagic markers, beclin1 and LC3 were detected by western blotting. Here, we found that LUT induced autophagy in U2OS and acted as an enhancer to sensitize doxorubicin (DOX)-mediated autophagy signaling. The combined treatment of LUT and DOX greatly decreases the growth of U2OS, showing synergistic cytotoxicity. Our results indicate that LUT in combination with DOX maybe a novel strategy for the treatment of human osteosarcoma.

Entities:  

Keywords:  Luteolin; autophagy; doxorubicin; human osteosarcoma

Year:  2015        PMID: 26629003      PMCID: PMC4658892     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

1.  Attenuation of doxorubicin-induced contractile and mitochondrial dysfunction in mouse heart by cellular glutathione peroxidase.

Authors:  Ye Xiong; Xuwan Liu; Chuan-Pu Lee; Balvin H L Chua; Ye-Shih Ho
Journal:  Free Radic Biol Med       Date:  2006-04-04       Impact factor: 7.376

2.  Modulation of multidrug resistance P-glycoprotein activity by antiemetic compounds in human doxorubicin-resistant sarcoma cells (MES-SA/Dx-5): implications on cancer therapy.

Authors:  A Angelini; P Conti; G Ciofani; F Cuccurullo; C Di Ilio
Journal:  J Biol Regul Homeost Agents       Date:  2013 Oct-Dec       Impact factor: 1.711

3.  Atypical paracaval recurrence of uterine endometrial stromal sarcoma: a case report.

Authors:  Nicolae Bacalbaşa; Irina Balescu
Journal:  Anticancer Res       Date:  2015-06       Impact factor: 2.480

4.  3-(4-(Benzo[d]thiazol-2-yl)-1-phenyl-1H-pyrazol-3-yl) phenyl acetate induced Hep G2 cell apoptosis through a ROS-mediated pathway.

Authors:  Jianyong Li; Zhijun Xu; Mengyao Tan; Weike Su; Xing-guo Gong
Journal:  Chem Biol Interact       Date:  2009-12-16       Impact factor: 5.192

Review 5.  Distribution and biological activities of the flavonoid luteolin.

Authors:  Miguel López-Lázaro
Journal:  Mini Rev Med Chem       Date:  2009-01       Impact factor: 3.862

Review 6.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

Review 7.  Autophagy as a cell death and tumor suppressor mechanism.

Authors:  Devrim Gozuacik; Adi Kimchi
Journal:  Oncogene       Date:  2004-04-12       Impact factor: 9.867

8.  Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model.

Authors:  Laura A Lambert; Na Qiao; Kelly K Hunt; Donald H Lambert; Gordon B Mills; Laurent Meijer; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

Review 9.  Cadmium induces reactive oxygen species generation and lipid peroxidation in cortical neurons in culture.

Authors:  E López; C Arce; M J Oset-Gasque; S Cañadas; M P González
Journal:  Free Radic Biol Med       Date:  2005-11-21       Impact factor: 7.376

10.  Autophagy-related gene 7 (ATG7) and reactive oxygen species/extracellular signal-regulated kinase regulate tetrandrine-induced autophagy in human hepatocellular carcinoma.

Authors:  Ke Gong; Chao Chen; Yao Zhan; Yan Chen; Zebo Huang; Wenhua Li
Journal:  J Biol Chem       Date:  2012-08-27       Impact factor: 5.157

View more
  3 in total

1.  Luteolin suppresses tumor proliferation through inducing apoptosis and autophagy via MAPK activation in glioma.

Authors:  Yijie You; Rong Wang; Naiyuan Shao; Feng Zhi; Yilin Yang
Journal:  Onco Targets Ther       Date:  2019-03-28       Impact factor: 4.147

2.  Luteolin attenuates the chemoresistance of osteosarcoma through inhibiting the PTN/β-catenin/MDR1 signaling axis by upregulating miR-384.

Authors:  Tao Qin; Wenjing Zhu; Xiaoli Kan; Ling Li; Dapeng Wu
Journal:  J Bone Oncol       Date:  2022-04-13       Impact factor: 4.491

3.  Luteolin Suppresses the Proliferation of Gastric Cancer Cells and Acts in Synergy with Oxaliplatin.

Authors:  Li-Qun Ren; Qi Li; Yang Zhang
Journal:  Biomed Res Int       Date:  2020-02-21       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.